Under the terms of the agreement, Hikma will have the exclusive rights to register, market and distribute Binosto in 19 countries across MENA.
The agreement will leverage Hikma’s strong local presence and regulatory expertise in MENA, …Read full article » Jordan: Sunday, February 03 - 2013 @ 15:55
A signing ceremony and press conference was held announcing Hikma’s exclusive rights for registering and marketing the new treatment.
Mr. Mazen Darwazeh, Hikma Pharmaceuticals Executive Vice Chairman and CEO of the Middle East and North …Read full article » Jordan: Thursday, November 24 - 2011 @ 11:52
Flammacerium is a sterile topical cream for the treatment and prevention of infections in extensive burn wounds. The product is a silver sulfadiazine cream with cerium nitrate to reduce the occurrence of immunosuppression which can …Read full article » Jordan: Monday, March 18 - 2013 @ 13:39
Hikma Pharmaceuticals PLC (“Hikma”) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), the fast growing multinational pharmaceutical group, today announces that it has signed an asset purchase agreement with Ben Venue Laboratories, Inc., a member of …Read full article » : Saturday, May 31 - 2014 @ 16:28
Hikma Pharmaceuticals PLC, the fast growing multinational pharmaceutical group, and a Regional Associate of the World Economic Forum, participated in the Davos Forum on January 22nd to 25th 2014, to showcase Hikma’s experience on how …Read full article » : Tuesday, February 04 - 2014 @ 08:50
Thaimorgan Ltd., Hikma’s affiliate company that specializes in cancer medication, obtained the necessary license for the production of cancer drugs and exportation to the United States. FDA approval for the drug shows the systematic and …Read full article » Jordan: Sunday, January 16 - 2011 @ 13:18
Scrip World Pharmaceutical News- the flagship title of the global pharmaceutical industry – recognises, through these Awards, the essential but often undervalued contribution of pharmaceutical and biotech companies to the improvement of healthcare worldwide.
Hikma won …Read full article » Jordan: Saturday, November 21 - 2009 @ 13:29
The sponsorship, lasting two years, was ratified at the National Center for Diabetes, Endocrinology and Genetics (NCDEG) on Sunday. Dr Salah Mawajdeh, Hikma’s Vice President of Regulatory and Medical affairs, and Professor Kamel Ajlouni, President …Read full article » Jordan: Monday, April 23 - 2012 @ 09:49
The summer camp is organized annually by the Jordanian Society for the Care of Diabetes (JSCD) with the support of many organizations that believe in providing an equal opportunity for children with diabetes, helping them …Read full article » Jordan: Tuesday, June 25 - 2013 @ 12:21
Dr. Mahmoud Sarhan, CEO and Director General of KHCC, expressed his gratitude to Hikma Pharmaceuticals for their support of the summer camp, an essential part of the comprehensive care pediatric patients receive, bringing them joy …Read full article » Jordan: Tuesday, July 20 - 2010 @ 11:54